Doctronic key facts
as of Oct 2026- Developer of a healthcare AI-based platform designed for real-time medical information and patient-doctor communication.
- Doctronic is valued at approximately $206.0M as of Oct 2026 (last reported valuation).
- It has raised $65.0M; the latest was Early Stage VC ($40.0M) in Feb 2026.
- Notable investors include Lightspeed Venture Partners, Abstract Ventures, Union Square Ventures, Mantis VC, Scott Belsky — 14 tracked in total.
- Status: Privately Held (backing).
Doctronic's last reported valuation, Feb 2026. Nothing priced has surfaced since.
- ·The complete investor list: 14 names
- ·Watch Doctronic: the Monday email on marks, rounds and moves
Doctronic funding rounds
No funding rounds for Doctronic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Doctronic
14+Doctronic valuation
Doctronic's last reported valuation was $206 million in Feb 2026. No priced round, secondary trade or fund mark has surfaced since.
Doctronic investors
14 investors are on record for Doctronic, including Lightspeed Venture Partners, Abstract Ventures, Union Square Ventures and Mantis VC. By type, the record holds 6 venture capital firms.
About Doctronic
Developer of a healthcare AI-based platform designed for real-time medical information and patient-doctor communication. The company's platform provides an AI doctor that analyzes health data and answers medical questions and offers integration with video visits with licensed doctors for prescriptions and referrals, secure storage of medical records, and continuous access to AI assistance for follow-up questions, enabling consumers to get accurate and personalized medical guidance and treatment effectively and affordably.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2023
- Employees
- 4
- Website
- doctronic.ai/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.